ContractEmployment Agreement • May 15th, 2007 • Idm Pharma, Inc. • Pharmaceutical preparations • California
This Employment Agreement (this “Agreement”) is made and entered into effective as of May 2, 2007 by and among IDM Pharma Inc., a Delaware corporation (the “Company”) and Robert De Vaere (the “Executive”). The Company and the Executive are hereinafter collectively referred to as the “Parties”, and individually referred to as a “Party”.
Employment ContractEmployment Contract • May 15th, 2007 • Idm Pharma, Inc. • Pharmaceutical preparations
The IDM S.A. Company (Immuno-Designed Molecules) with a capital of 2,194,500 F, SIRET 382 632 26300036, with its headquarters at 172, rue de Charonne, 75011 Paris, Represented by Mr. Yves FOURON, its Chief Executive Officer and Chairman of the Board,
CONSULTING AGREEMENT EFFECTIVE DATE: May 1, 2007Consulting Agreement • May 15th, 2007 • Idm Pharma, Inc. • Pharmaceutical preparations • California
This Consulting Agreement (the “Agreement") is made by and between IDM Pharma, Inc., a Delaware corporation (the “Company”), and John P. McKearn, Ph.D., an individual and a member of the Company’s Board of Directors (the “Consultant”) effective May 1, 2007.
Employment Agreement By and Between Epimmune Inc. and Bonnie MillsEmployment Agreement • May 15th, 2007 • Idm Pharma, Inc. • Pharmaceutical preparations • California
This Employment Agreement (this “Agreement”) is made and entered into as of June 6, 2005 by and among EPIMMUNE INC., a Delaware corporation (the “Company”) and Bonnie Mills (the “Executive”). This Agreement shall become effective (the “Effective Date”) as of the closing date of that certain Share Exchange Agreement made and entered into as of March 15, 2005 (the “Exchange Agreement”), as amended, between the Company and certain shareholders of IDM, S.A., a société anonyme organized under the laws of France (“IDM”). The Company and the Executive are hereinafter collectively referred to as the “Parties”, and individually referred to as a “Party”. Those capitalized terms used herein and not otherwise defined shall have the meanings given to such terms in the Exchange Agreement.
